APOE and early-onset autosomal dominant Alzheimer disease: We finally assessed whether the implicated APOE4-dysregulated lysosomal proteins from our LysoIP experiments are conserved across large-scale studies using proteomic datasets from the Accelerating Medicines Partnership – Alzheimer Disease (AMP-AD) consortium [95].